Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)

Market Cap	11.16B +4.6%
Revenue (ttm)	3.91B +4.5%
Net Income	590.51M +10.6%
EPS	1.37 +10.4%
Shares Out	431.05M
PE Ratio	18.90
Forward PE	14.35
Dividend	0.62 (2.39%)
Ex-Dividend Date	Aug 8, 2025

Volume	3,426,358
Average Volume	3,502,577
Open	25.87
Previous Close	25.96
Day's Range	25.76 - 26.11
52-Week Range	24.61 - 31.46
Beta	0.43
RSI	56.91
Earnings Date	Apr 25, 2026

About SHA:600993

Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells Chinese and Western medicines in China and internationally. The company offers functional cosmetics, functional care products and food, Chinese herbal medicines, and medical devices. It also manufactures, processes, and sells medicinal packaging materials, cosmetics, and Chinese medicines; and offers first and second category medical devices, household products, electronic products, daily necessities, hygiene products, and disinfection products, as...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1582
• Employees: 2,654
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600993

Financial Performance

In 2025, SHA:600993's revenue was 3.87 billion, an increase of 3.72% compared to the previous year's 3.73 billion. Earnings were 581.49 million, an increase of 10.11%.